This review discusses the pathophysiological mechanisms and clinical aspects of TZP in treating obesity
Hormonal changes following surgery compound the challenge
Members access detailed dosing calculators, side effect management strategies, and real-world guidance from experienced users who understand the complexities of GLP-1 therapy
Coverage for obesity drugs, including GLP1 medications, rose to 44% of large employers (500+ employees) in 2024, and 64% of the largest employers (20,000+ employees) now offer this coverage, according to data from Mercer
Ability to understand the study, voluntarily participate, and provide written informed consent
Automatic full refunds will be made for any course with a live-course component that has been cancelled